I. Introduction
Aрpellees Rx Depot, Inc., Rx of Canada, LLC, Carl Moore, and David Peoples (collectively “Rx Depot”) facilitated the sale of prescription drugs from Canada to customers in the United States. The United States brought suit against Rx Depot, alleging its business practices violated provisions of the Federal Food, Drug and Cosmetic Act (“FDCA”), 21 U.S.C. §§ 301-397. Rx Depot admitted to violating the Act and entered into a consent decree of permanent injunction. Subsequently, the United States sought disgorgement of Rx Depot’s profits. The district court denied disgorgement, concluding it was not an available remedy under the FDCA as a matter of law. We exercise jurisdiction pursuant to 28 U.S.C. § 1291. Because the FDCA invokes courts’ general equity jurisdiction and does not prohibit disgorgement by clear legislative command or nec *1054 essary and inescapable inference, we reverse and remand.
II. Background
Rx Depot helped consumers in the United States obtain prescription drugs from Canada at reduced prices. A customer with a prescription from an American physician could download forms from Rx Depot’s website or visit one of Rx Depot’s storefront affiliates to order medications. Rx Depot then transmitted the customer’s forms, prescription, and paymеnt information to cooperating Canadian pharmacies. A Canadian physician would rewrite the prescription, which was then filled by a Canadian pharmacy and sent directly to the customer in the United States. Rx Depot received a ten to twelve percent commission for each sale they facilitated.
The United States filed a civil action alleging Rx Depot’s activities violated provisions of the FDCA. Specifically, the government alleged Rx Depot violated § 381(d)(1) by reimporting prescription drugs originally manufactured in the United States and § 355(a) by introducing new drugs intо interstate commerce without FDA approval. The government sought a temporary and permanent injunction and other equitable relief. The district court entered a preliminary injunction ordering Rx Depot to discontinue its business activities. The parties then agreed to, and the district court approved, a consent decree of permanent injunction. In the consent decree, Rx Depot admitted to violating the FDCA and agreed not to resume its business operations. The consent decree left “to the discretion of [the district court] the issue of what, if any, equitable relief, including restitution and/or disgorgement, should be awarded to [the United States].”
Subsequently, the district court denied restitution, reasoning Rx Depot’s customers did not lose money in their transactions because they purchased medications at reduced prices. The district court initially concluded disgorgement would be an appropriate remedy. Upon reconsideration, however, the district court determined disgorgement was not available under the FDCA as a matter of law. Although the FDCA invokes courts’ equity jurisdiction, the district court determined the Act’s express provision of other remedies and legislative history create a necessary and inescapable inference that Congress intended to restrict courts’ power to order disgorgement. The United States appeals only the district court’s denial of disgorgement.
III. Discussion
We review questions of statutory interpretation
de novo. Employers Reinsurance Corp. v. Mid-Continent Cas. Co.,
In
Porter v. Warner Holding Co.,
the Supreme Court held when Congress invokes the equity jurisdiction of courts in a statute, “all the inherent equitable powers of the [courts] are available for the proper and complete exercise of that jurisdiction,” unless the statute, by “clear and valid legislative command” or “necessary and inescapable inference,” restricts the forms of equitable relief authorized.
Arguably, the Court’s decision in
Porter
also relied in part on the broad language of § 205(a), which authorized “any ... other order.”
See id.
at 399,
Amicus argues our analysis of the remedies available under the FDCA should be guided by
Meghrig v. KFC Western, Inc.
instead of
Porter
and
Mitchell. Meghrig,
First, the Court reasoned the clear language of RCRA’s citizen suit provision precludes an order of restitution for past cleanup costs.
Id.
at 486,
Second, the Court found evidence that Congress did not intend to authorize restitution of past cleanup costs in both the structure of RCRA and its relation to another environmental statute. RCRA prohibits citizen suits when either the EPA or the State has commenced a separate enforcement action. 42 U.S.C. § 6972(b)(2)(B) & (C). Thus, if RCRA permitted restitution for past cleanup costs, it would only provide compensation in those cases in which waste problems are not severe or substantial enough to attract governmental attention.
Meghrig,
The Court’s analysis also relied on significant differences between RCRA and the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”). CERCLA, which was enacted several years after RCRA, contains a citizen suit provision which mimics RCRA’s and authorizes courts “to order such action as may be necessary to correct” violations of the Act.
Id.
at 485,
Finally, the Court noted an award of past cleanup costs is inconsistent with RCRA’s purposes.
Id.
at 483,
Thus, rather than overruling or limiting
Porter’s
and
Mitchell’s
general rule that a grant of equity jurisdiction enables courts to order any form of equitable relief,
Me-ghrig
merely demonstrates that a statute’s particular characteristics may preclude application of the rule.
See Meghrig,
*1058
Section 332(a) of the FDCA invokes the equity jurisdiction of courts using the same statutory language the Supreme Court construed in
Mitchell
to authorize all traditional equitable remedies.
Compare
21 U.S.C. § 332(a) (“district courts ... shall have jurisdiction, for cause shown to restrain violations”),
with
29 U.S.C. § 217 (“district courts ... shall have jurisdiction, for cause shown, to restrain violations”);
see Mitchell,
Rx Depot and amicus first contend the text of the FDCA limits the remedies available under the Act to forward-looking remedies. They argue the term “restrain” in § 332(a) envisions stopping ongoing violations of the Act or preventing future ones, not punishing past violations. Thus, they urge, the backward-looking remedy of disgorgement is expressly prohibited by the statute.
In
Mitchell,
the Supreme Court interpreted the statutory command “to restrain violations” to permit the arguably backward-looking remedy of restitution.
Rx Depot and amicus also rely on
United States v. Philip Morris USA, Inc.
in
*1059
arguing that a statutory grant of equity jurisdiction “to restrain violations” authorizes only forward-looking remedies.
to prevent and restrain violations of [RICO] by issuing appropriate orders, including, but not limited to: ordering any person to divest himself of any interest, direct or indirect, in any enterprise; imposing reasonable restrictions on the future activities or investments of any person ...; or ordering dissolution or reorganization of any enterprise....
18 U.S.C. § 1964(a). Citing Meghrig, the court reasoned the statutory language “to prevent and restrain” limited courts to ordering forward-looking remedies aimed at preventing future violations of the Act. Id. at 1199. But see id. at 1220-22 (Tatel, J., dissenting) (arguing that Porter and Mitchell, not Meghrig, control). The court also relied on the fact that the remedies enumerated in the statute’s jurisdictional grant are all forward-looking. Thus, the court applied the canons noscitur a sociis and ejusdem generis to conclude that any authorized remedies beyond those specifically mentioned in the statute must be similarly forward-looking. Id. at 1200. But see id. at 1224 (Tatel, J., dissenting) (questioning the applicability of the canons in light of the statute’s cоmmand that the list of remedies is not exhaustive).
Although we express no opinion regarding whether, or in what circumstances, disgorgement is authorized under RICO, Philip Morris is inapposite to our decision here because the court relied on statutory language in RICO not present in the FDCA. See id. at 1199 (“In the RICO Act, Congress provided a statute granting jurisdiction defined with the sort of limitations not present in the FLSA or the EPCA.”). In any event, we note that Philip Morris did not question the continued validity of Porter and Mitchell, the cases we rely on here. See id. at 1200 (ruling out disgorgement remedy using Porter test). 5
Rx Depot and amicus next contend that because the FDCA explicitly authorizes certain remedies, we should be reluctant to infer additional remedies. Defendants and amicus fail to rеcognize that by granting courts general equity jurisdiction, Congress authorized all traditional equitable remedies. As the Court noted in
Mitchell,
“[w]hen Congress entrusts to an equity court the enforcement of prohibitions contained in a regulatory enactment, it must be taken to have acted cognizant of the historic power of equity to provide complete relief in the light of statutory purposes.”
In
Porter,
the Court determined the express provision of certain remedies in the EPCA did not create a necessary and inescapable inference limiting courts’ authority to order unenumerated equitable remedies.
The express remedies provided in the FDCA are similar to those available under the EPCA. In addition to general equity jurisdiction, the FDCA explicitly provides for criminal, civil, and administrative remedies. See 21 U.S.C. § 333 (providing for criminal fines and imprisonment and civil monetary penalties); id. § 360h(b) & (e) (authorizing Secretary of Health and Human Services (“Secretary”) to order recall, repair, replacement, or refund of purchase price for medical devices); id. § 350a(e)(l)(B) (authorizing Secretary to recall adulterated or misbranded infant formula); id. § 360pp(a) & (b) (granting district courts equity jurisdiction and providing for civil monetary penalties for violation of statutory provisions relating to electronic products). These remedies are no more expansive or comprehensive than those found in the EPCA. Seizure is the only express remedy provided for in the FDCA that was not also authorized by the EPCA. Id. § 334. This single additional remеdy, however, does not create a necessary and inescapable inference that Congress intended to exclude all other remedies.
Amicus further argues the specific authorization of restitution for certain medical devices in one provision of the FDCA shows Congress did not intend to allow disgorgement under another provision of the Act. The FDCA permits the Secretary to order the manufacturer, importer, or distributor of a medical device found in violation of the Act to refund the purchase price of the device to customers. Id. § 360h(b)(2)(C). Before ordering а refund, the Secretary must determine that the device presents an unreasonable risk of substantial harm to the public health; there are reasonable grounds to believe the device is defective; the defect was caused by the manufacturer, importer, distributor, or retailer; and other remedies are inadequate to eliminate the risk posed by the device. Id. § 360h(b)(l)(A). Ami-cus contends the detailed showing required to permit restitution is inconsistent with the view that Congress intended to provide for the similar remedy of disgorgement upon a mere showing of a violation of the Act.
This argument is unpersuasive. Section 360h describes only the Secretary’s powers in administering the Act. The section says nothing about remedies that may be ordered by courts. We decline to read the FDCA’s grant of expanded administrative powers as a diminishment of the federal courts’ judicial powers under a grant of general equity jurisdiction.
See Porter,
*1061
Finally, Rx Depot argues the legislative history of the FDCA, which indicates that Congress intended seizure to be the harshest remedy available under the Act, precludes disgorgement. We are not convinced, however, that seizure is harsher than disgorgement in all circumstances.
See United States v. Universal Mgmt. Servs., Inc.,
Because the FDCA does not contain a clear legislative command or compel a necessary and inescapable inference precluding disgorgement, an order of disgorgement is permitted if it furthers the purposes of the FDCA.
See Porter,
In sum, the FDCA invokes courts’ general equity jurisdiction by authorizing courts “to restrain violations” of the Act. This broad grant of equity jurisdiction is not restricted by the text of the statute, its express provision of certain legal and administrative remedies, or its legislative history. Moreover, disgorgement furthers the purposes of the FDCA by detеrring future violations of the Act which may put the public health and safety at risk. Therefore, according to the analysis established in Porter and Mitchell, we conclude disgorgement is permitted under the FDCA in appropriate cases. 6
Our determination that disgorgement is authorized by the FDCA is supported by decisions in several other circuits. Although we are the first circuit to address disgorgement under the FDCA, two circuits have held recently that restitution is *1062 authorized by the Act. These decisions, and the analysis employed by the courts in reaching them, substantiate our reasoning here.
In
Universal Management,
the Sixth Circuit upheld an order of restitution requiring а party who sold adulterated medical devices to provide refunds to its customers.
The Third Circuit similarly upheld the authority of courts to order restitution under the FDCA in a case involving mis-branding of and failure to obtain FDA approval for dietary supplements and skin cream purported to prevent and treat cancer.
United States v. Lane Labs-USA Inc.,
The only other circuit to address restitution under the FDCA is the Ninth Circuit. In 1956, the court held that restitution is not available under the FDCA in
United States v. Parkinson,
IV. Conclusion
For the foregoing reasons, this court REVERSES the district court’s denial of disgorgement and REMANDS the matter for further proceedings not inconsistent with this opinion.
Notes
. Section 205(a) provided:
[T]he Administrator [of the Office of Price Administration] may make application tо the appropriate court for an order enjoining ... acts or practices [in violation of the statute] ... and upon a showing by the Administrator ... [of] such acts or practices a permanent or temporary injunction, restraining order, or other order shall be granted without bond.
Emergency Price Control Act of 1942, § 205(a), 56 Stat. 23, 33.
. RCRA's citizen suit provision authorizes district courts "to restrain any person who has contributed or who is contributing to the past or present handling, storage, treatment, transportation, or disposal of any solid or hazardous waste ..., to order such person to take such other action as may be necessary, or both....” 42 U.S.C. § 6972(a).
. Amicus contends that by implying additional remedies in a statute where Congress authorized only specified forms of relief,
Mitchell
exemplifies the type of analysis the Supreme Court once employed in implying private rights of action. Amicus notes that the Supreme Court abandoned implying private rights of action in
Alexander v. Sandoval,
and argues the Court similarly abandoned implying equitable remedies in
Meghrig. Sandoval,
. It is not clear that disgorgement is solely a backward-looking remedy. One purpose of disgorgement is to deter future violations of the law by making illegal conduct unprofitable.
See Porter,
. Two other circuits have concluded RICO does not categorically prohibit disgorgement.
See Richard v. Hoechst Celanese Chem. Group, Inc.,
. Because the district court determined disgorgement was not available under the FDCA, it did not examine whether there were any ill-gotten gains to be disgorged or whether disgorgement was appropriate under the facts of this case. Therefore, we remand for the district court to address this issue in the first instance.
See R. Eric Peterson Constr. Co. v. Quintek, Inc. (In re R. Eric Peterson Constr. Co.),
